Back to search results

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

Israel
RecruitingPHASE3

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Carcinoma, Renal Cell

Locations
  • Macquarie University ( Site 2700), Macquarie University, New South Wales, Australia
  • Rambam Health Care Campus ( Site 1600), Haifa, Israel
  • Samsung Medical Center ( Site 2902), Seoul, South Korea
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)